SCHEMBL29480681

SCHEMBL29480681

Nc1nccc(-c2cnn(CC(F)(F)F)c2)c1N

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 3/20 0.44
▸ PIK3CD O00329 4/20 0.40
▸ PIK3CB P42338 4/20 0.40
▸ PIK3CG P48736 4/20 0.40
▸ MTOR P42345 3/20 0.40
▸ CTSD P07339 2/20 0.38
▸ BACE1 P56817 2/20 0.38
▸ BACE2 Q9Y5Z0 2/20 0.38
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 1/20 0.36
▸ PIM1 P11309 2/20 0.36
▸ PIM3 Q86V86 2/20 0.36
▸ PIM2 Q9P1W9 2/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ MET P08581 2/20 0.35
▸ FFAR1 O14842 1/20 0.35
▸ CCNC P24863 1/20 0.35
▸ CDK8 P49336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17203201 0.74 PIK3CD (0.46) LRRK2PIK3CDPIK3CBPIK3CGMTOR
SCHEMBL22736088 0.73 AURKA (0.52) LRRK2MTORALOX5APFEN1CCNC
SCHEMBL31182236 0.73 METAP2 (0.50) PIK3CDPIK3CBPIK3CGMTORCTSD
SCHEMBL22735762 0.73 JAK1 (0.41) PIK3CDPIM1IRAK4MET
SCHEMBL18985800 0.70 MEN1 (0.42) LRRK2PIK3CDPIK3CBPIK3CGALOX5AP
SCHEMBL28734614 0.69 LRRK2 (0.41) LRRK2PIK3CDPIK3CBPIK3CGMTOR
SCHEMBL611806 0.68 MAPT (0.47) LRRK2PIK3CDPIK3CBPIK3CGMTOR
SCHEMBL20905869 0.68 LRRK2 (0.43) LRRK2PIM1PIM3PIM2MET
SCHEMBL30961412 0.68 FFAR1 (0.41) LRRK2PIK3CDPIK3CBPIK3CGMTOR
SCHEMBL30961453 0.68 IRAK4 (0.41) LRRK2PIK3CDPIK3CBPIK3CGMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 — — CN disclosed
Send feedback